# Bison Capital (China)

> Bison Capital (China) is a VC fund in Beijing backing Health Care, Medical and Blockchain. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 3
- Last investment: Jun 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.bisoncapital.cn/

Bison Capital (China) is a VC fund in Beijing focused on Health Care and Medical. Bison Capital is an investment firm provides focus on medical, media and financial fields and deals in M&A transactions.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Blockchain | 1 | 33% |
| Data Storage | 1 | 33% |
| Biotechnology | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| Australia | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Verida | Verida is a decentralized data platform that empowers users to take control of their personal data and digital identities. The company provides a secure wallet and network infrastructure to enable users to manage their crypto assets, verifiable credentials, and encrypted personal data. Verida merged with Kwaai in 2025. | $5M | Seed | Jun 21, 2024 |  |
| AMCARELAB | AMCARELAB includes three major disciplines : clinical cytogenetics, Clinical Biochemistry, and Clinical Molecular Genetics. | $29.9M | Series B | Jun 09, 2022 |  |
| Help Therapeutics | Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health. | $25M | Series C | Nov 15, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Amesten Capital](https://shizune.co/investors/profile/amesten-capital) — VC Fund, 1 deal together
- [ChaiTech Ventures](https://shizune.co/investors/profile/chaitech-ventures) — VC Fund, 1 deal together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 1 deal together
- [Gate Labs](https://shizune.co/investors/profile/gate-labs) — VC Fund, 1 deal together
- [Golden Rain Bogor](https://shizune.co/investors/profile/golden-rain-bogor) — VC Fund, 1 deal together
- [Guangdong Technology Financial Group](https://shizune.co/investors/profile/guangdong-technology-financial-group) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund
- [Polychain](https://shizune.co/investors/profile/polychain-capital) — VC Fund
- [Digital Currency Group](https://shizune.co/investors/profile/digital-currency-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Cryptocurrency Investors in Australia](https://shizune.co/investors/cryptocurrency-investors-australia)
- [Cryptocurrency VC Funds in Australia](https://shizune.co/investors/cryptocurrency-vc-funds-australia)
- [Cryptocurrency VC Funds in Oceania](https://shizune.co/investors/cryptocurrency-vc-funds-oceania)
- [Web3 Investors in Australia](https://shizune.co/investors/web3-investors-australia)
- [Cryptocurrency Investors in Oceania](https://shizune.co/investors/cryptocurrency-investors-oceania)

## FAQ

### What does Bison Capital (China) invest in?

Bison Capital (China) invests primarily in Health Care, Medical and Blockchain startups, most often at Seed and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Bison Capital (China) last invest?

The most recent investment recorded for Bison Capital (China) closed in Jun 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co